Night shift workers face documented health risks from circadian disruption, including increased rates of cancer, cardiovascular disease, and metabolic disorders. A new preliminary study provides evidence-based insights into how melatonin supplementation might mitigate these risks at the cellular level.
Key findings suggest that melatonin may restore DNA repair processes disrupted by overnight work schedules, potentially serving as a complementary intervention to existing workplace health strategies. The hormone functions both as a direct antioxidant and as a regulator of DNA repair enzymes, addressing the fundamental mechanism by which circadian disruption harms cellular maintenance.
While these results are promising for the millions of essential workers maintaining overnight schedules, researchers emphasize that larger clinical trials are necessary before establishing definitive supplementation protocols. Workers interested in melatonin should consult healthcare providers to determine appropriate dosing and individual suitability.
Read the full article on GMJ Newsroom.
Was this article helpful?
